RISK BASED INSPECTION [SCHEDULE M-POINT (39.3)]
![RISK BASED INSPECTION [SCHEDULE M-POINT (39.3)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-39.3-768x1087.jpg)
Schedule M – Point 39.3 (Microbiology Lab) in a Risk-Based Inspection (RBI) focuses on whether the firm has an appropriate microbiology laboratory layout and can briefly describe it (with a layout drawing, if available). CDSCO In RBI, this point is…





![RISK BASED INSPECTION [SCHEDULE L1-POINT (38.5)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-L1-38.5-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE L1-POINT (38.4)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-L1-38.4-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.16)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-34.16-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.15)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-34.15-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.14)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-34.14-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.13)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-34.13-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.11-34.12)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-34.11-34.12-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.9-34.10)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-34.9-34.10-768x1087.jpg)
![RISK BASED INSPECTION [WHO TRS 986-POINT (34.8)]](https://pharmadevils.com/wp-content/uploads/2024/11/WHO-TRS-986-34.8-1-768x1087.jpg)